Furthermore, IDH1+ and IDH2+ leukemias differ in their mutational profiles, with high incidence of DNA (cytosine-5)-methyltransferase 3A (DNMT3A) mutations reported in IDH1+, but not IDH2-R140+ AML38,43. The gene discussed is IDH2; the disease is leukemia.